Claro Advisors LLC raised its stake in MetLife, Inc. (NYSE:MET – Free Report) by 2.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,483 shares of the financial services provider’s stock after buying an additional 308 shares during the period. Claro Advisors LLC’s holdings in MetLife were worth $1,112,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of MET. Swedbank AB bought a new position in shares of MetLife in the first quarter valued at $131,456,000. Acadian Asset Management LLC raised its stake in MetLife by 7,837.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock valued at $79,250,000 after purchasing an additional 1,115,124 shares during the period. Dimensional Fund Advisors LP raised its stake in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after purchasing an additional 988,666 shares during the period. Bessemer Group Inc. raised its stake in MetLife by 29.7% during the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after purchasing an additional 485,811 shares during the period. Finally, Public Sector Pension Investment Board raised its stake in MetLife by 347.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock valued at $30,384,000 after purchasing an additional 336,127 shares during the period. Institutional investors own 89.81% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the stock. Wells Fargo & Company boosted their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Bank of America cut their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Barclays dropped their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday, October 31st. Piper Sandler upped their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Finally, TD Cowen began coverage on shares of MetLife in a research note on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price target on the stock. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $88.46.
MetLife Stock Up 0.9 %
MET stock opened at $83.33 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 52-week low of $61.61 and a 52-week high of $86.94. The company has a 50-day moving average of $81.60 and a two-hundred day moving average of $75.62. The stock has a market capitalization of $57.70 billion, a price-to-earnings ratio of 16.80, a price-to-earnings-growth ratio of 0.76 and a beta of 1.05.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Energy and Oil Stocks Explained
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Where Do I Find 52-Week Highs and Lows?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is a buyback in stocks? A comprehensive guide for investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.